Storia in 2 fonti

Relation promises 'transformationally different success rates' in expanded AI pact with GSK

Relation expands its GSK partnership for up to $110M, tapping new AI model MORGAN to sharpen drug discovery and biology insights.

Raccontata da

thenextweb.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo15 g fa

Relation promises 'transformationally different success rates' in expanded AI pact with GSK

Relation expands its GSK partnership for up to $110M, tapping new AI model MORGAN to sharpen drug discovery and biology insights.

originale

thenextweb.com15 g fa

Relation unveils MORGAN, a cell model, plus a $110M GSK deal

Relation Therapeutics unveiled MORGAN, a foundation model predicting how cells respond to genetic and drug changes, backed by $110M from GSK for generating petascale perturbation datasets. Big Pharma now views foundation model data infrastructure as drug discovery's core competitive asset—a structural shift from traditional finished-drug focus to AI-biology systems.

Leggi questa versione →

Timeline cronologica

giovedì 30 luglio 2026·thenextweb.com
Relation unveils MORGAN, a cell model, plus a $110M GSK deal
Relation unveiled MORGAN, an AI “foundation model of the cell,” plus a GSK deal worth up to $110m to make the data to train it.
giovedì 30 luglio 2026·endpoints.news
Relation promises 'transformationally different success rates' in expanded AI pact with GSK
Relation expands its GSK partnership for up to $110M, tapping new AI model MORGAN to sharpen drug discovery and biology insights.